Greenhill in 2020

have not found a solid, up-to-date thread on GHL. I know it’s not the place it used to be but how far is it from being an EB. Exit opps/culture/compensation/analyst experience? Would anyone choose GHL over a low-tier BB?

92 Comments
 

Not sure about US but in London - deal flow not be what it used to but culture is top. Filled with very smart and genuine people at the junior level. Think they work long hours though.

 

I know two kids who work there in NY. One of them leaves the office at like 8pm every night.. the other like 11pm. Still have a three year analyst program which is something to note as a lot of banks are promoting or kicking you out after two. In terms of dealflow, I imagine not great to be honest. I've never crossed paths with them on anything. I'd imagine it's mostly mm work. Probably a good bank if you care about work life balance at least in NY and fine with mostly mm exits.

 

Well-above street comp and lean teams, but definitely not what it use to be. More of a strong upper-MM rather than EB. Would take a low/mid BB or JEF over it at this point (this is for NA).

 

I'd say they're still an EM, on some very large mandates but not as frequent as before. Agreed that I would take it over a low BB or JEF, but given the trajectory, I'd choose any of the EB summer offers over it. RX has unbearably bad culture though. Former Rothschild bankers

 

I wasn't referring to UBS/DB at all. Those are not BBs and yes GHL is a better pick (at least surely not UBS). I was referring to CS/RBC/Barclays. Jefferies has a very strong platform with some great growth and deal flow over the last few years while GHL has trended in the opposite direction during a period where just about everyone else (besides some of the European banks) have been growing. GHL only serious advantage is being so lean and it's why they are able to grab such high quality analysts.

 

Note that GHL is really small - typical analyst class is around 10. Know a couple people who work there, and while they don't do a ton of big deals in absolute numbers, the class is so small that everyone is getting quality experience.

 

How are folks assessing whether GHL is an EB? Deal volume? They’re a fraction of the size of most other boutiques and purely focus on M&A / Restructuring. Analyst class has incredibly strong placements still and, from what I hear, culture is amazing with great work / life balance.

Love when Interns / College kids post shit they know nothing about.

 
Most Helpful

Not a whole lot of good Greenhill info out there so I'll try to contribute what I can from experience/talking to others. Feel free to PM.

On the Rx side, the team was growing fast and doing well before the Covid-induced recession. Of course, heavy dealflow now; many deals aren't public but you can see some on Reorg. Class size of 3 analysts expanded to 6, added multiple MDs. The team works hard but relatively little facetime and seniors are willing to put in a good word for you on the buyside when recruiting time comes around. Culture has improved and isn't the same as it was at Rothschild. Still a small sample at this point since the group is new, but exits have included Centerbridge, Cerberus, TPG Sixth Street, and a credit hedge fund.

Mostly accurate on the M&A side. Deal flow can be variable (as banker832 alluded to), but you also need to remember how small the class size is. Analysts seem to enjoy the experience with good culture and solid exit ops. You can search these on past WSO posts or LinkedIn; many end up at top UMM firms (ie., Vista Equity, CD&R, Lindsay Goldberg, Silver Lake). Some BB groups might be different, but my friends at the BBs have typically been one of many analysts on a deal.

 

Have heard very good things from PWP and their Rx deal flow seems strong as well. Keep in mind they are M&A/Rx for interns so that could make a difference depending on what you want. Word is that Rothschild dealflow has slowed since the key departures over last couple years, but I can't really know for sure (would be helpful if anyone who knows can jump in). Also generalist M&A/rx internship.

 

FWIW, Greenhill's interview was one of the hardest that I went through while recruiting (I'm from a semi-target that had supers at most of the EBs).

Seems like they're pretty selective not just on smarts but also fit as well. Analyst class is probably solid

 

I interviewed for M&A. Very technical interview and dug pretty deep on the behavioral side. Everyone was really respectful tho and I'm sure those guys have fun (no elitist feel like you would experience at Lazard for example)

 

Guggenheim RX. The combined Millstein platform is very strong and from what I've heard has good culture. Recently mandated on American Airlines

 

If you want to give MS, why don't you also explain why you feel differently. Why is Greenhill RX better

 

Disagree about relatively weak. Guggenheim had an RX platform before and added Millstein so it's pretty established

 

My two cents’ on GHL: (overall, very positive)

  • Extremely intelligent bankers
  • Above street compensation
  • Blue chip clients
  • MD’s from tier-1 BB banks
  • Low face-time culture
  • Excellent exit ops for Analysts
  • Rigorous interview process
  • Typical deals range from $500M to $1B+
  • Deals focus on M&A, restructuring, divestitures, carve outs, spin offs, etc.

However:

  • Stock price on the decline (even pre-Covid)
  • Brand name not known outside of IB community
  • Prestigious within the IB community varies

There has been a lot of attention on how banks respond to Covid. If GHL follows Citi’s internship approach (e.g., guaranteed FT offers, full 10-weeks pay, shortened / virtual internship), as well as maintains the GHL sign-on / minority bonuses, then I believe GHL will re-gain the street credit the bank used to wield.

 

Still a great bank but the trajectory of the place is so so. Mostly great, smart people some OK people (like any other good bank). To determine whether to take GHL over a "low-tier BB", you would have to dive deeper into the group / vertical.

In short - not enough info to say for sure.

"If a grasshopper tries to fight a lawnmower, one may admire his courage but not his judgement.." - Robert Heinlein
 

Greenhill was what Evercore is now 10-15 years ago. Since then, they've been on a steady decline and can and should not be considered an EB (in my humble opinion the only true EBs right now are Lazard, Evercore, Centerview). From what I understand, culture and comp is good at the analyst level but light deal flow and weak brand name recognition. Mostly MM deals and many top bankers have left or the ones hanging around are no longer at top of their game

 

Didn't know they certified interns, they should definitely reconsider that in the future

To live is to suffer, to survive is to find some meaning in the suffering.
 
Controversial

Wow. Posted for the first time in a while out of boredom and surprised I got hit with 14 MS's. I happened to have come from a complete non-target with a blue collar family background and have now been in this industry for more than half a decade. I think I know a thing or two more than these dimwit college kids who now get offers before they've even lost their virginity.

Moelis? I don't consider a firm that does a ton of small MM deals with a ton of mediocre pitch-heavy MDs an "EB." Moelis may have been top 15 in the league tables last year but they were in the 20s the year before (as well as in 2017 if my memory serves right). That's on worse on paper than Jefferies, Rothschild, Guggenheim, and BNP Paribas.

PWP? They're incredibly overrated and always have been. I remember when they were founded, they came out of the gate with incredible hype and big name hires, but never established itself among Evercore, Lazard, Centerview (side note: when they were founded in 2006, Greenhill was on par or better than Evercore, and Lazard was the top EB by miles and miles. There was also Gleacher & Co., which didn't last but was considered a real EB for some time.) Additionally, just by having the names "Perella" and "Weinberg" doesn't make them a top, elite firm so no, I would not categorize them as an "EB." I don't remember the last time they cracked top 20 league tables and other than a few one-offs, you just don't see them around the most high profile transactions. They were supposed to go public last year, but that whole process stalled because of lack of investor interest in the company and its overall performance.

PJT? Rising star but I would not put them in the same category yet as the three firms I keep alluding to. They had a good year last year driven by ~3-4 huge deals. In 2-3 years I could see them mentioned among those top 3, but for now have much to prove.

As I said this is all my opinion. Open to debating. If not, you can just listen to advice from "financestudent2020"

PS: Talk to anyone who's actually been in the industry for the past 3+ years. No one in their right mind considers PWP or Moelis in the same league as Evercore/Lazard/Centerview. PJT maybe, but definitely not PWP or Moelis.

 

Besides what you said about PJT (which I strongly disagree with, I would look into it again seriously), I agree with just about everything else you said. Maybe a bunch of butthurt GHL/Moelis analysts on here slinging you MS lol. This site has become more and more of a joke, same people throwing shit at you think that UBS/DB/CS are still relevant lmao.

 

The fact that you are using M&A league table standing as barometer for boutique firm success/quality really demonstrates your lack of understanding of the boutique business model - they don't chase scale and are not trying to be "everything to everyone"

Part of the reason MDs leave BBs to join EBs is that they are the afforded the opportunity and latitude to focus on the situations and clients of their choosing, without a group head breathing down their neck about making budget or why they weren't on the ticket for an M&A deal that printed that morning

 

Interesting, but I disagree with your thinking. How do YOU define "EB" exactly? Do people not put these firms in this category because of their deal success, as opposed to business model?

People on WSO and sites like M&I use the term Elite Boutique to list names of firms that have top deal volume success. So yes, league tables absolutely should be used as a barometer.

If not, why don't you just call every MM/Boutique an "Elite Boutique" ??? I mean heck, if you think EBs are just firms that BB MDs leave for, why don't you call Union Square Advisors an EB? They have bankers who came from BAML, Barclays, etc.

 

I think there's a lot of disconnect between people's perspectives on what an EB is. A lot of the rankings on this site are based on PE placement and subjective prestige (which is influenced by PE placement). And so when we think of an EB we think of a firm that places well into PE/has prestige. If I were considering a career in banking I would start off at a BB for sure, work my way up, and at the MD level, once I've established myself, leave for an EB where I'd have more autonomy and a higher commission. And I think that's where you're coming from. The perspective of someone in it for the long run.

However, only a fraction of us are probably trying to do that. The rest (at least the ones who haven't switched completely out of IB) are probably thinking about exiting to PE. And so in this case, when you trash the T2 EBs, most of us see it as saying the exits aren't good. Whereas you'd probably place better as a generalist at Moelis than at the worst group at MS, despite MS being top tier. A lot of people would probably choose some T2 EBs over some T1 EBs because the placements are equal, but you have a smaller class and you get paid better.

 

I have heard good things about the culture—I had a friend in the last class and apparently out of 10 (NY M&A) summer analysts, all 10 received offers and all 10 accepted their offers.

 

Sint est aliquid quidem. Voluptas iste unde voluptatem omnis voluptas cupiditate modi quidem. Doloribus dolores at debitis quis. Quis tenetur eligendi deleniti aut. Adipisci beatae aliquam dolores incidunt. Delectus suscipit voluptatum voluptatem voluptas quia.

Quis sed et voluptatem aut libero. Ab debitis alias enim velit nemo quidem placeat. Facere nemo et non tempora qui architecto perferendis. Tenetur rerum ea voluptatem delectus et. Eum blanditiis eum dolores molestiae quod voluptates soluta.

Dignissimos quaerat est doloremque eos illum. Eum ipsa recusandae fugiat neque amet. Nam voluptas et quaerat aut.

Facilis expedita harum sit delectus facilis est eaque ut. Dolor occaecati officia asperiores occaecati asperiores optio. Omnis et ab et quia quasi quas. Placeat inventore quo voluptas. Nihil non laborum repudiandae ipsum eaque. Ullam ea facere sed sint omnis. Dolorem a facilis commodi reprehenderit expedita deserunt at.

 

Ratione suscipit animi debitis ad. Autem quasi omnis vero fuga. Quia autem dolores corporis voluptates doloremque voluptatum nobis. Cum impedit quasi inventore quia vero.

Magnam quia voluptas atque porro sint ab cumque. Esse corporis excepturi ut. Ut expedita est deleniti totam amet.

 

Quasi velit deserunt ut itaque quis velit repudiandae. Et non odit a maxime aut id. Debitis earum aut nulla ut velit sed. Maiores mollitia occaecati rem nulla eos dolores magnam in.

Iusto ut ex laborum dolores voluptatibus ab animi. Quo nemo illum libero iure laboriosam quod consequatur. Aspernatur non aut nostrum voluptatem. Autem voluptas harum ducimus est odit et.

Et similique dolor consequatur hic nemo ut et. Aut illum tempora quas aut ab illo. Voluptas voluptas consequatur consectetur doloremque ea ex. Ipsam esse est enim libero rem rerum nostrum.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”